Pharmacokinetics of esomeprazole following intravenous and oral administration in healthy dogs

References

• ShinJMKimNPharmacokinetics and pharmacodynamics of the proton pump inhibitorsJ Neurogastroenterol Motil2013191253523350044
   PubMed Web of Science ®Google Scholar
• KodamaKFujisakiHKubotaAE3710, a new proton pump inhibitor, with a long-lasting inhibitory effect on gastric acid secretionJ Pharmacol Exp Ther2010334239540120484556
   PubMedGoogle Scholar
• WallmarkBLarssonHHumbleLThe relationship between gastric acid secretion and gastric H+, K+-ATPase activityJ Biol Chem19852602513681136842997178
   PubMed Web of Science ®Google Scholar
• TolbertKBissettSKingAEfficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogsJ Vet Intern Med2011251475421143305
   PubMed Web of Science ®Google Scholar
• BersenasAMMathewsKAAllenDGConlonPDEffects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogsAm J Vet Res200566342543115822586
   PubMedGoogle Scholar
• WilliamsonKKWillardMDPaytonMEDavisMSEfficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogsJ Vet Intern Med201024228528820102495
   PubMedGoogle Scholar
• TolbertMKOdunayoAHowellRSPetersEEReedAEfficacy of intravenous administration of combined acid suppressants in healthy dogsJ Vet Intern Med201529255656025711717
   PubMedGoogle Scholar
• JohnsonDAReview of esomeprazole in the treatment of acid disordersExpert Opin Pharmacother20034225326412562316
   PubMed Web of Science ®Google Scholar
• NichitaCAbdouAEMaertenPA single dose of intravenous esomeprazole decreases gastric secretion in healthy volunteersAliment Pharmacol Ther200930101022102919702644
   PubMed Web of Science ®Google Scholar
• LindTRydbergLKylebackAEsomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux diseaseAliment Pharmacol Ther200014786186710886041
   PubMed Web of Science ®Google Scholar
• MöschwitzerJAchleitnerGPomperHMüllerRHDevelopment of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technologyEur J Pharm Biopharm200458361561915451536
   PubMed Web of Science ®Google Scholar
• Wilder-SmithCHBondarovPLundgrenMIntravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studiesEur J Gastroenterol Hepatol200517219119715674097
   PubMed Web of Science ®Google Scholar
• StantonMEBrightRMGastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature reviewJ Vet Intern Med1989342382442685273
   PubMedGoogle Scholar
• HendersonAKWebsterCRDisruption of the gastric mucosal barrier in dogsCompend Contin Educ Vet200628340353
   Google Scholar
• CariouMLipscombVJBrockmanDJGregorySPBainesSJSpontaneous gastroduodenal perforations in dogs: a retrospective study of 15 casesVet Rec20091651543644119820258
   PubMed Web of Science ®Google Scholar
• BartgesJWChronic kidney disease in dogs and catsVet Clin of North Am Small Anim Pract2012424669692vi22720808
   PubMed Web of Science ®Google Scholar
• WeisseCBerentACToddKSolomonJACopeCEndovascular evaluation and treatment of intrahepatic portosystemic shunts in dogs: 100 cases (2001–2011)J Am Vet Med Assoc20142441789424344856
   PubMedGoogle Scholar
• PantiABennettRCCorlettoFBrearleyJJefferyNMellanbyRJThe effect of omeprazole on oesophageal pH in dogs during anaesthesiaJ Small Anim Pract2009501054054419796313
   PubMed Web of Science ®Google Scholar
• SellonRKWillardMDEsophagitis and esophageal stricturesVet Clin North Am Small Anim Pract200333594596714552156
   PubMedGoogle Scholar
• LeibMSDinnelHWardDLReimerMETowellTLMonroeWEEndoscopic balloon dilation of benign esophageal strictures in dogs and catsJ Vet Intern Med200115654755211817059
   PubMedGoogle Scholar
• MunsterMHoraufALubke-BeckerAGrestPRuttenMIdiopathic esophagopathies resembling gastroesophageal reflux disease in dogsTierärztl Prax Ausg K Kleintiere Heimtiere201341317317923765362
   PubMedGoogle Scholar
• DavisMSWillardMDNelsonSLEfficacy of omeprazole for the prevention of exercise-induced gastritis in racing Alaskan sled dogsJ Vet Intern Med200317216316612683615
   PubMed Web of Science ®Google Scholar
• MirzaeianSSarachahiAAShojaee TabriziADerakhshandehAEradication of gastric Helicobacter spp. by triple therapy in dogsVet Med (Praha)20135811582586
   Web of Science ®Google Scholar
• ZacutoACMarksSLOsbornJThe influence of esomeprazole and cisapride on gastroesophageal reflux during anesthesia in dogsJ Vet Intern Med201226351852522489656
   PubMed Web of Science ®Google Scholar
• Hassan-AlinMAnderssonTBredbergERohssKPharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjectsEur J Clin Pharmacol200056910665670
   Google Scholar
• SykesBWUnderwoodCMcGowanCMMillsPCPharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horseJ Vet Pharmacol Ther201538213013625271390
   PubMedGoogle Scholar
• ZhangYHuoMZhouJXieSPKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft ExcelComput Methods Programs Biomed201099330631420176408
   PubMed Web of Science ®Google Scholar
• LarssonHCarlssonEJunggrenUInhibition of gastric acid secretion by omeprazole in the dog and ratGastroenterology19838549009076884713
   PubMedGoogle Scholar
• ToutainPLBousquet-MelouAPlasma terminal half-lifeJ Vet Pharmacol Ther200427642743915601438
   PubMed Web of Science ®Google Scholar
• AnderssonTAndrenKCederbergCLagerstromPOLundborgPSkanbergIPharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjectsBr J Clin Pharmacol19902955575632350532
   PubMed Web of Science ®Google Scholar
• HultmanIStenhoffHLiljebladMDetermination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20078482317322
   PubMed Web of Science ®Google Scholar
• YangXMaQDetermination of esomeprazole in dog plasma by LC-MS-MSJ Pharmaceut Prac201316163
   PubMedGoogle Scholar
• ShiSKlotzUProton pump inhibitors: an update of their clinical use and pharmacokineticsEur J Clin Pharmacol2008641093595118679668
   PubMed Web of Science ®Google Scholar
• SimonBMullerPPascuOIntra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux diseaseEur J Gastroenterol Hepatol200315779179912811310
   PubMed Web of Science ®Google Scholar
• LarssonHMattssonHCarlssonEGastric acid antisecretory effect of two different dosage forms of omeprazole during prolonged oral treatment in the gastric fistula dogScand J Gastroenterol1988238101310193201125
   PubMed Web of Science ®Google Scholar
• NerellaNGBlockLHNoonanPKThe impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open modelPharmaceut Res199310710311036
   PubMedGoogle Scholar
• AnderssonTRohssKBredbergEHassan-AlinMPharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazoleAliment Pharmacol Ther200115101563156911563995
   PubMed Web of Science ®Google Scholar
• AnderssonTSingle-isomer drugs: true therapeutic advancesClinical Pharmacokinetics200443527928515080761
   PubMedGoogle Scholar
• AnderssonTHassan-AlinMHasselgrenGRohssKWeidolfLPharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazoleClinical Pharmacokinetics200140641142611475467
   PubMed Web of Science ®Google Scholar
• LarssonHMattsonHSundellGCarlssonEAnimal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivoScand J Gastroenterol Supp19851082335
   PubMedGoogle Scholar
• MetzDCMinerPBHeumanDMChenYSostekMComparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux diseaseAliment Pharmacol Ther200522981382116225490
   PubMedGoogle Scholar
• SostekMBChenYAnderssonTEffect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazoleBr J Clin Pharmacol200764338639017425628
   PubMed Web of Science ®Google Scholar
• JunghardOHassan-AlinMHasselgrenGThe effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pHEur J Clin Pharmacol200258745345812389067
   PubMedGoogle Scholar